DynoSense Corp

About DynoSense Corp

DynoSense Corp. operates within the digital medical technology sector, focusing on remote patient monitoring solutions. Founded in March 2013 by Saeed Azimi, a technology industry veteran who previously served as CEO of Vital Connect, the company is headquartered in Sunnyvale, California. The firm targets several market segments, including elderly managed care, chronic disease management, post-hospital discharge care, and telemedicine. Its business model revolves around providing hardware and a cloud-based data analytics platform to consumers, healthcare providers, and insurance companies to facilitate preventative care and more informed health decisions.

The company's core offering is the Dyno, a multi-function health scanner designed to capture a wide array of health metrics in under 60 seconds. This device measures key vital signs such as electrocardiogram (ECG), respiration rate, body temperature, blood oxygen saturation (SpO2), pulse rate, and heart rate. Unlike traditional monitors that process data locally, the Dyno wirelessly transmits raw data via the DynoLife mobile application to a HIPAA-compliant cloud platform. On the cloud, an intelligent analytic engine processes the information, with the capability to interpret changes in blood pressure, perfusion index, and certain cardiac ailments like Atrial Fibrillation (AFib). This data is then made available to healthcare professionals through the company's Health Relationship Management Services (HRMS) software, which helps aggregate patient data to create personalized care plans.

Financially, DynoSense has secured approximately $10.1 million through multiple funding rounds, including a significant $9.4 million Series A in August 2015. This funding was raised from investors such as WI Harper Group, Plug and Play Tech Center, and JKOM Cloud Health Technology. A key milestone was achieved in August 2019 when the company received FDA clearance for its Vital Signs Measuring System, paving the way for commercialization which was planned for the first half of 2020.